SL Science Holding SLBT
NASDAQ SLBT
$1.21 +0.02 (+1.68%)
At close: Oct 28, 2026 · 4:00 PM EDT

SL Science Holding (SLBT) Cash from Operations (2025 - 2026)

Updated

SL Science Holding's Cash from Operations came in at -$1.88 million for Q2 2026, compared with $147,787 a year earlier.

Analysis

SL Science Holding (SLBT) Cash from Operations (2025 - 2026) Analysis & Trends

For FY2025, SL Science Holding's Cash from Operations was -$1.91 million.

  • Going back by year, Cash from Operations was $280,158 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,213.59 Bn 1,182.17 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 652.89 Bn 572.75 Bn 17.30 Bn 7.72 Bn
3 AbbVie 506.16 Bn 479.31 Bn 12.70 Bn 3.44 Bn
4 Merck 347.97 Bn 302.40 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 297.84 Bn 271.42 Bn - -
6 Astrazeneca 262.79 Bn 236.55 Bn 12.86 Bn 2.87 Bn
7 Amgen 244.26 Bn 199.66 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 197.57 Bn 171.68 Bn 6.22 Bn 3.57 Bn
9 Pfizer 168.03 Bn 114.97 Bn 10.94 Bn 835.00 Mn
10 SL Science Holding 2.64 Bn 2.62 Bn - -1.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.88 Mn
Mar 31, 2026 -214,981.00
Jun 30, 2025 147,787.00
API Access

SL Science Holding Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=SLBT&period=max&api_key=YOUR_API_KEY